CRISPR Therapeutics CRSP
Last Price
52 Week Range
$30.04 - $78.48
Next Earnings Date
Feb 10 2026 (Estimate)
Next Earnings Date
Feb 10 2026 (Est.)
Last Price
CRSP Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
CRISPR Therapeutics AG | 8-K | November 10, 2025 | |
CRISPR Therapeutics AG | 10-Q | November 10, 2025 | |
CRISPR Therapeutics AG | 8-K | October 15, 2025 | |
CRISPR Therapeutics AG | 10-Q | August 4, 2025 | |
CRISPR Therapeutics AG | 8-K | August 4, 2025 | |
CRISPR Therapeutics AG | 8-K | June 26, 2025 | |
CRISPR Therapeutics AG | 8-K | June 9, 2025 | |
CRISPR Therapeutics AG | 8-K | May 19, 2025 | |
CRISPR Therapeutics AG | 8-K | May 6, 2025 | |
CRISPR Therapeutics AG | 10-Q | May 6, 2025 | |
CRISPR Therapeutics AG | ARS | April 16, 2025 | |
CRISPR Therapeutics AG | DEF 14A | April 16, 2025 | |
CRISPR Therapeutics AG | DEFA14A | April 16, 2025 | |
CRISPR Therapeutics AG | PRE 14A | April 3, 2025 | |
CRISPR Therapeutics AG | 8-K | March 26, 2025 | |
CRISPR Therapeutics AG | 8-K | February 11, 2025 | |
CRISPR Therapeutics AG | 10-K | February 11, 2025 | |
CRISPR Therapeutics AG | 10-Q | November 5, 2024 | |
CRISPR Therapeutics AG | 8-K | November 5, 2024 | |
CRISPR Therapeutics AG | 8-K | August 5, 2024 | |
CRISPR Therapeutics AG | 10-Q | August 5, 2024 | |
CRISPR Therapeutics AG | S3ASR | August 5, 2024 | |
CRISPR Therapeutics AG | 8-K | June 3, 2024 | |
CRISPR Therapeutics AG | 8-K | May 23, 2024 | |
CRISPR Therapeutics AG | 10-Q | May 8, 2024 | |
CRISPR Therapeutics AG | 8-K | May 8, 2024 | |
CRISPR Therapeutics AG | DEF 14A | April 9, 2024 | |
CRISPR Therapeutics AG | DEFA14A | April 9, 2024 | |
CRISPR Therapeutics AG | ARS | April 9, 2024 | |
CRISPR Therapeutics AG | PRE 14A | March 27, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.